Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Certain NK cell changes in blood may indicate alopecia areata progression.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Arg1+ macrophages may play a role in causing alopecia areata.

Lacrimal gland inflammation and alopecia areata can happen together due to autoimmune issues.

Alopecia areata may be linked to heart issues.

Homeopathic treatment may help manage alopecia areata effectively.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Clonally expanded CD8+ T cells cause alopecia areata.

Alopecia can be linked to autoimmune diseases and shows different hair loss patterns.

Alopecia areata patients have a higher risk of subclinical atherosclerosis, and carotid ultrasound can help assess their cardiovascular risk.

The woman was diagnosed with systemic lupus erythematosus (SLE) after initial misdiagnosis and improved with proper treatment.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

ILC1 cells contribute to hair loss in alopecia areata.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

People with Down syndrome have a higher risk of autoimmune diseases, so early detection and care are important.

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.